Basilea Pharmaceutica AG (SWX:BSLN)
49.60
-0.60 (-1.20%)
Jun 2, 2026, 5:30 PM CET
Basilea Pharmaceutica AG Employees
Basilea Pharmaceutica AG had 189 employees as of December 31, 2025. The number of employees increased by 25 or 15.24% compared to the previous year.
Employees
189
Change (1Y)
25
Growth (1Y)
15.24%
Revenue / Employee
1.23M CHF
Profits / Employee
212.91K CHF
Market Cap
622.27M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 189 | 25 | 15.24% |
| Dec 31, 2024 | 164 | 17 | 11.56% |
| Dec 31, 2023 | 147 | 6 | 4.26% |
| Dec 31, 2022 | 141 | -13 | -8.44% |
| Dec 31, 2021 | 154 | -3 | -1.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bachem Holding AG | 2,595 |
| Idorsia | 487 |
| Molecular Partners AG | 134 |
| Santhera Pharmaceuticals Holding AG | 94 |
| BioVersys AG | 33 |
| Newron Pharmaceuticals | 27 |
| Xlife Sciences AG | 17 |
| Addex Therapeutics | 2 |
Basilea Pharmaceutica AG News
- 5 days ago - Basilea receives further USD 13 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam - GlobeNewsWire
- 5 days ago - Basilea Pharmaceutica AG Slides: Investor presentation - Filings
- 6 weeks ago - Basilea shareholders approve all proposals of the board of directors at the 2026 annual general meeting - GlobeNewsWire
- 7 weeks ago - Basilea awarded additional CARB-X funding of USD 6 million to support the clinical development of antibiotic BAL2420 - GlobeNewsWire
- 2 months ago - Basilea Pharmaceutica AG Slides: Investor presentation - Filings
- 2 months ago - Basilea Pharmaceutica AG Slides: Investor presentation - Filings
- 2 months ago - Basilea announces start of first‑in‑human study of novel antibiotic BAL2420 - GlobeNewsWire
- 3 months ago - Basilea receives further USD 6 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam - GlobeNewsWire